RHBDF2 and thromboangiitis obliterans: –12 By coupling Apts with PLGA microspheres, we aim to achieve sustained and controlled delivery of Toc directly to CD34+ orbital fibroblasts, thereby enhancing therapeutic efficacy, minimizing systemic side effects, and improving clinical outcomes in patients with TAO by attenuating inflammation and fibrosis.